Piper Sandler analyst David Westenberg lowered the firm’s price target on Neogen (NEOG) to $5 from $6.40 and keeps a Neutral rating on the shares. The firm cites a slower ramp in operating margins.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NEOG:
- Neogen to sell cleaners, disinfectants business to Kersia Group for $130M
- Neogen’s Strategic Shift and Market Positioning Justifies Buy Rating
- Neogen price target lowered to $6.40 from $13 at Piper Sandler
- Neogen price target lowered to $13 from $15 at Guggenheim
- Neogen Reports Q3 2025 Earnings Amid Challenges